| AMI | Acute Myocardial Infarction - Complications(Cx) 1. Early ... |
|---|---|
| DSS | 1) Double Simultaneous Stimulation 2) Dengue Shock Syndrome |
| ECG | Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ = EKG 1. Conducting System Structu... |
| EST(?) | Electric(Electro-) Shock Theraphy; Àü±â Ãæ°ÝÄ¡·á = ECT |
| ESWL | Extracorporeal Shock-Wave Lithotripsy - Ix for Gall Stone  ... |
| insulin-stimulating peptide | <chemical> 71-amino acid containing peptide; corresponds to residues 115-143 and 144-184 of bovine serum albumin with the exception of a tyrosine insertion between residues 155 and 156; consists of two chains with mw 5000 and 3400 for each chain Synonym: h-isp, insulin-stimulating protein (05 Dec 1998) |
|---|---|
| insulin unit | The activity contained in 1/22 mg of the international standard of zinc-insulin crystals. (05 Mar 2000) |
| insulin zinc suspension | A sterile buffered suspension with zinc chloride, containing 40 or 80 units per ml; the solid phase of the suspension consists of a mixture of 7 parts of crystalline insulin and 3 parts of amorphous insulin. Synonym: lente insulin. (05 Mar 2000) |
| extended insulin zinc suspension | A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours. Synonym: crystalline insulin zinc suspension. (05 Mar 2000) |
| ultralente insulin | A form of zinc precipitated insulin in suspension in which the particle size is large, and thus release into the bloodstream after subcutaneous injection is slow; it can be mixed with other insulins having different particle sizes to achieve different durations of activity. Can be derived from porcine, bovine, or genetically engineered human type. (05 Mar 2000) |
| lente insulin | A sterile buffered suspension with zinc chloride, containing 40 or 80 units per ml; the solid phase of the suspension consists of a mixture of 7 parts of crystalline insulin and 3 parts of amorphous insulin. Synonym: lente insulin. (05 Mar 2000) |
| anaesthetic shock | Shock produced by the administration of anaesthetic drug(s), usually in relative overdosage. (05 Mar 2000) |
| anaphylactic shock | <immunology> A serious, often life-threatening allergic reaction that is characterised by low blood pressure, shock (poor tissue perfusion) and difficulty breathing. (27 Sep 1997) |
| anaphylactoid shock | A reaction that is similar to anaphylactic shock, but which does not require the incubation period characteristic of induced sensitivity (anaphylaxis); it is unrelated to antigen-antibody reactions. Synonym: anaphylactoid crisis, pseudoanaphylactic shock. (05 Mar 2000) |
| break shock | The shock produced by breaking a constant current passing through the body. (05 Mar 2000) |
| cardiac shock | A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy. Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully. (27 Sep 1997) |
| cardiogenic shock | A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy. Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully. (27 Sep 1997) |
| cardiopulmonary obstructive shock | <cardiology> This term describes a number of conditions that involve a severe disturbance of the cardiopulmonary circuit resulting in shock (inadequate delivery of oxygen to the tissues). Examples include: pulmonary embolism, pericardial tamponade, pneumothorax and constrictive pericarditis. (27 Sep 1997) |
| vasogenic shock | Shock resulting from depressed activity of the higher vasomotor centres in the brain stem and the medulla, producing vasodilation without loss of fluid so that the container is disproportionately large. In oligaemic shock, blood volume is reduced; in both, return of venous blood is inadequate. (05 Mar 2000) |
| reversible shock | Shock that will respond to treatment and from which recovery is possible. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|